Armando López-Guillermo Selected Research

Circulating Tumor DNA

1/2021

Mutational Landscape and Tumor Burden Assessed by Cell-free DNA in Diffuse Large B-Cell Lymphoma in a Population-Based Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Armando López-Guillermo Research Topics

Disease

36	Neoplasms (Cancer) 01/2024 - 06/2002
27	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 10/2023 - 11/2002
18	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 02/2023 - 06/2002
17	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 10/2023 - 09/2002
16	Lymphoma (Lymphomas) 02/2023 - 04/2003
12	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2024 - 11/2004
7	B-Cell Lymphoma (Lymphoma, B Cell) 01/2024 - 01/2004
6	Non-Hodgkin Lymphoma (Lymphosarcoma) 10/2023 - 10/2002
5	Hodgkin Disease (Hodgkin's Disease) 02/2023 - 09/2002
5	Infections 11/2021 - 03/2003
4	Residual Neoplasm 10/2022 - 11/2002
3	Cytopenia 01/2022 - 03/2003
3	Disease Progression 01/2019 - 11/2004
2	Multiple Myeloma 01/2021 - 01/2020
2	Second Primary Neoplasms (Neoplasms, Second) 10/2017 - 10/2011
2	Cryoglobulinemia 03/2004 - 08/2003
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 02/2023
1	Lymphadenopathy 01/2022
1	Lymphopenia (Lymphocytopenia) 11/2021
1	Invasive Fungal Infections 11/2021
1	Breast Neoplasms (Breast Cancer) 01/2021
1	T-Cell Lymphoma (Lymphoma, T Cell) 04/2020
1	Febrile Neutropenia 01/2018
1	Trisomy (Trisomies) 01/2018
1	Neutropenia 01/2018

Drug/Important Bio-Agent (IBA)

26	Rituximab (Mabthera)FDA Link 10/2022 - 01/2004
8	Cyclophosphamide (Cytoxan)FDA LinkGeneric 04/2017 - 09/2002
7	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2024 - 09/2004
7	Proteins (Proteins, Gene)FDA Link 01/2021 - 09/2002
7	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2012 - 05/2006
6	Biomarkers (Surrogate Marker)IBA 01/2024 - 11/2002
5	Vincristine (Oncovin)FDA LinkGeneric 09/2012 - 05/2006
5	Prednisone (Sone)FDA LinkGeneric 09/2012 - 05/2006
4	RNA (Ribonucleic Acid)IBA 10/2023 - 02/2014
4	ibrutinibIBA 01/2023 - 02/2016
4	Cyclin D1IBA 01/2021 - 09/2013
4	Mitoxantrone (Novantrone)FDA LinkGeneric 04/2017 - 09/2002
4	Messenger RNA (mRNA)IBA 12/2011 - 01/2006
3	idelalisibIBA 11/2021 - 02/2016
3	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2019 - 10/2002
3	Bendamustine Hydrochloride FDA Link 01/2019 - 02/2016
3	Etoposide (VP 16)FDA LinkGeneric 01/2019 - 10/2002
3	ChromatinIBA 01/2018 - 11/2013
3	Lenalidomide (CC 5013)FDA Link 01/2018 - 04/2016
3	fludarabineIBA 04/2017 - 09/2002
3	DNA (Deoxyribonucleic Acid)IBA 11/2012 - 06/2002
2	Long Noncoding RNAIBA 10/2023 - 01/2019
2	Interleukin-1 Receptor-Associated KinasesIBA 12/2022 - 10/2021
2	Protein Isoforms (Isoforms)IBA 12/2022 - 01/2018
2	Cell-Free Nucleic AcidsIBA 06/2022 - 01/2021
2	Monoclonal AntibodiesIBA 11/2021 - 03/2017
2	venetoclaxIBA 11/2021 - 01/2020
2	CyclinsIBA 01/2021 - 11/2009
2	daratumumabIBA 01/2020 - 03/2017
2	CytokinesIBA 01/2020 - 01/2019
2	Interleukin-6 (Interleukin 6)IBA 01/2020 - 01/2017
2	CryoglobulinsIBA 01/2017 - 03/2003
2	Bleomycin (Blenoxane)FDA LinkGeneric 10/2009 - 02/2007
2	Dacarbazine (DIC)FDA LinkGeneric 10/2009 - 02/2007
2	Vinblastine (Vinblastine Sulfate)FDA Link 10/2009 - 02/2007
2	Ifosfamide FDA LinkGeneric 04/2003 - 10/2002
2	Dexamethasone (Maxidex)FDA LinkGeneric 10/2002 - 09/2002
1	axicabtagene ciloleucelIBA 01/2024
1	Chimeric Antigen ReceptorsIBA 10/2023
1	Programmed Cell Death 1 ReceptorIBA 02/2023
1	isatuximabIBA 02/2023
1	cemiplimabIBA 02/2023
1	NF-kappa B (NF-kB)IBA 01/2023
1	Liver X ReceptorsIBA 12/2022
1	Basic Helix-Loop-Helix Transcription FactorsIBA 01/2022
1	Hexachlorobenzene (HCB)IBA 01/2022
1	ibritumomab tiuxetan (Zevalin)FDA Link 01/2022
1	Serum AlbuminIBA 01/2022
1	CD40 Ligand (CD40L)IBA 12/2021
1	ofatumumab FDA Link 11/2021
1	obinutuzumabIBA 11/2021
1	acalabrutinibIBA 11/2021
1	NivolumabIBA 11/2021
1	pembrolizumabIBA 11/2021
1	Circulating Tumor DNAIBA 01/2021
1	Macrophage Colony-Stimulating FactorIBA 01/2021
1	A-Form DNA (A-DNA)IBA 11/2020
1	Anaplastic Lymphoma KinaseIBA 04/2020
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2020
1	SuspensionsIBA 01/2019
1	CPI203IBA 01/2019
1	Melphalan (Alkeran)FDA LinkGeneric 01/2019
1	Carmustine (FIVB)FDA Link 01/2019
1	Chemokine ReceptorsIBA 01/2019
1	Agammaglobulinaemia Tyrosine KinaseIBA 11/2017
1	spebrutinibIBA 11/2017
1	Dihydrotachysterol (AT 10)IBA 10/2017

Therapy/Procedure

21	Therapeutics 01/2022 - 11/2002
19	Drug Therapy (Chemotherapy) 01/2024 - 06/2002
10	Stem Cell Transplantation 12/2019 - 10/2002
5	Immunotherapy 01/2023 - 01/2018
3	Salvage Therapy 01/2023 - 04/2003
3	Highly Active Antiretroviral Therapy (HAART) 02/2008 - 09/2002
2	Secondary Prevention 12/2019 - 12/2018
1	Transplantation 01/2024